All the information on the eMC website comes directly from pharmaceutical companies. Approximately 200 pharmaceutical companies subscribe to the eMC and so pay Datapharm to publish their information on the eMC website. This is how the information is approved and added.

  1. The pharmaceutical company drafts a Summary of Product Characteristics (known as anĀ SmPC) and Patient Information Leaflet (known as a PIL, Package Leaflet or PL), using all the up to date information about their medicine.
  2. The UK or European medicines licensing agency - the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) - then checks and approves the information.
  3. The pharmaceutical company publishes the approved SmPC and PIL on the eMC website.